| Roche: Tecentriq cocktail slows kidney cancer progression | | | ZURICH (Reuters) - Combining Roche's Tecentriq immunotherapy with its older drug Avastin reduced the risk of disease worsening or death (PFS) for the initial treatment of advanced kidney cancer in some patients, the Swiss drugmaker said on Monday |
| |
| Merck raises stakes in lung cancer as rivals close in | | | LOS ANGELES (Reuters) - Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer. |
| |
| Hospital operators in merger talks to form U.S. industry leader: WSJ | | | NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in talks about a merger between the two Catholic non-profits that would create the largest U.S. hospital chain, the Wall Street Journal reported on Sunday, citing people familiar with the discussions. |
| |
| Novartis CAR-T therapy leads to durable response in lymphoma study | | | (Reuters) - Patients with an advanced form of an aggressive blood cancer who had initially responded to Novartis' new type of gene-modifying immunotherapy continued to respond at least six months after treatment, according to updated data released at a medical meeting on Sunday. |
| |
| Roche lymphoma drug drives high remission rate, longer survival: study | | | (Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday. |
| |
| 'Unheard of' responses to bluebird CAR-T therapy seen in myeloma study | | | (Reuters) - More than half of patients with advanced multiple myeloma who had run out of therapeutic options remained in complete remission after receiving bluebird bio Inc's experimental gene-modifying immunotherapy in a small, early stage study, according to updated data released on Sunday. |
| |
| France orders international recall of Lactalis baby formula | | | PARIS (Reuters) - France has ordered banned the sale and ordered a recall of several baby formula milk and baby food products made by French dairy giant Lactalis after the discovery of salmonella bacteria, consumer protection agency DGCCRF said in a statement. |
| |
| | |
